Background Fistulising perianal Crohn’s disease (CD) remains a debilitating condition, with few randomised controlled trials ...

Read more about how standardized outcome measures and design parameters impact Fragile X Syndrome clinical trials in a new ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centersCompany ...

Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic disease, ...

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centers Company to hold Type D meeting with FDA to discuss a potential ...

Introduction Colorectal cancer (CRC) screening reduces cancer incidence and mortality, but participation rates are suboptimal ...

Researchers conducted a cross-sectional analysis of recent myeloma randomized clinical trials to evaluate the prevalence and characteristics of reporting spin in study findings.

CHICAGO--ClostraBio, a biotechnology company developing next-generation probiotics to support gut health, today announced the ...

Introduction Self-management is a key component of effective chronic obstructive pulmonary disease (COPD) management and is ...

Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with shamat one year in patients receiving complete ...

OKYO Pharma Limited has filed its annual report on Form 20-F for the fiscal year ended March 31, 2026, with the US Securities ...